Sequence information
DRAVP ID DRAVPc048
Name Hepalatide
Sequence
Molecular Formula Not Available
Condition/Disease Chronic HBV infection
Group Phase Ⅱ clinical trial
Type Peptide
Description Hepalatide is used for the treatment of chronic hepatitis B virus infection.
Active sequence/Structure
External Links
DrugBank Accession Number Not Available
Pubchem ID 438788936
CHEMBL ID Not Available
UNII 8WL68J66B9
CAS Not Available
Reference Not Available
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT02612506 | Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers | Hepatitis B， Chronic | Completed | Phase 1 | Shanghai HEP Pharmaceutical Co., Ltd. |
| NCT03023787 | Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers | Hepatitis B， Chronic | Completed | Phase 1 | Shanghai HEP Pharmaceutical Co., Ltd. |
| NCT04426968 | A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B | Hepatitis B， Chronic | Completed | Phase 2 | Shanghai HEP Pharmaceutical Co., Ltd. |
